KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2026)

Amneal Pharmaceuticals has reported Tax Rate over the past 9 years, most recently at 10.25% for Q4 2025.

  • For Q4 2025, Tax Rate rose 4565.0% year-over-year to 10.25%; the TTM value through Dec 2025 reached 8.1%, up 4239.0%, while the annual FY2025 figure was 8.1%, 4239.0% up from the prior year.
  • Tax Rate for Q4 2025 was 10.25% at Amneal Pharmaceuticals, down from 447.16% in the prior quarter.
  • Over five years, Tax Rate peaked at 447.16% in Q3 2025 and troughed at 198.19% in Q3 2021.
  • A 5-year average of 27.28% and a median of 5.07% in 2021 define the central range for Tax Rate.
  • Biggest five-year swings in Tax Rate: surged 81333bps in 2021 and later tumbled -22016bps in 2023.
  • Year by year, Tax Rate stood at 25.39% in 2021, then skyrocketed by 193bps to 23.51% in 2022, then plummeted by -150bps to 11.8% in 2023, then plummeted by -200bps to 35.4% in 2024, then surged by 129bps to 10.25% in 2025.
  • Business Quant data shows Tax Rate for AMRX at 10.25% in Q4 2025, 447.16% in Q3 2025, and 31.14% in Q2 2025.